These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7022923)

  • 1. Migratory behavior of lymphocytes during allograft rejection.
    Hoffman RA; Ascher NL; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1102-4. PubMed ID: 7022923
    [No Abstract]   [Full Text] [Related]  

  • 2. Maturation of cytotoxic effector cells at the site of allograft rejection.
    Ascher NL; Chen S; Hoffman R; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1105-7. PubMed ID: 6973856
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of allograft rejection in New Zealand mice. II. Role of a serum factor.
    Gelfand MC; Parker LM; Steinberg AD
    J Immunol; 1974 Jul; 113(1):1-8. PubMed ID: 4598887
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruitment of lymphocytes to sponge matrix allografts.
    Hopt UT; Sullivan W; Simmons RL
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1086-90. PubMed ID: 7022919
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological disease induced by injecting F1 lymphoid cells into certain parental strains.
    Simpson E; O'Hopp S; Harrison M; Mosier D; Melief K; Cantor H
    Immunology; 1974 Dec; 27(6):989-1007. PubMed ID: 4156027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
    Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
    Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor activity of the lymphocytes of BALB/c and C57BL mice during methylcholanthrene carcinogenesis].
    Umanskiĭ IuA; Semenova-Kobzar' RA; Kushko LIa; Tovmachenko NN
    Vopr Onkol; 1976; 22(6):40-4. PubMed ID: 969342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of cytokine production within the rejecting allograft.
    Ford HR; Hoffman RA; Wang SA; Simmons RL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):251-2. PubMed ID: 1990526
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific migration of antigen-sensitive lymphocytes form the spleen to the site of allograft.
    Olszewski WL; Stepkowski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):529-34. PubMed ID: 7036937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
    Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
    J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragraft distribution of lymphocytes expressing beta7 integrins after small bowel transplantation in mice.
    Kellersmann R; Ulrichs K; Kellersmann A; Thiede A
    Transpl Immunol; 2004 Dec; 13(4):249-58. PubMed ID: 15589737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems.
    Chandradasa KD
    Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carrageenan and high serum dilution on synergistic cytotoxicity to tumor cells.
    Pollack S; Nelson K
    J Immunol; 1973 May; 110(5):1440-3. PubMed ID: 4697837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.